These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2058123)

  • 1. [The cyclophosphamide treatment of glomerulonephritis patients].
    Dorets'kyĭ VV
    Vrach Delo; 1991 Feb; (2):51-3. PubMed ID: 2058123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppressors and immunostimulants in the treatment of chronic glomerulonephritis patients with the nephrotic syndrome].
    Nazar PS
    Vrach Delo; 1987 Mar; (3):86-9. PubMed ID: 3590711
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunogenesis and hemostasis in patients with exacerbated chronic glomerulonephritis treated with thymalin].
    Budazhabon GV; Kuznik BI; Morozov VG; Orlova NN; Khavinson VKh
    Ter Arkh; 1984; 56(10):62-6. PubMed ID: 6549229
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological criteria of the activity of glomerulonephritis].
    Buglova SE; Chizh KA; Samusik LV
    Ter Arkh; 1992; 64(11):75-9. PubMed ID: 1293851
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
    Krasnova TN; Shilov EM; Ivanov AA; Samoĭlov DV; Gordovskaia NB; Miroshnichenko NG; Tareeva IE
    Ter Arkh; 1991; 63(6):115-8. PubMed ID: 1948725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome].
    Duman VL
    Ter Arkh; 2002; 74(6):39-41. PubMed ID: 12136481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of cyclophosphamide in membranoproliferative glomerulonephritis].
    Wills H; Villarreal H
    Arch Inst Cardiol Mex; 1976; 46(6):770-5. PubMed ID: 1023835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the effectiveness of Cyclophosphamide and Cytembena in controlled clinical trial in nephrotic syndrome and chronic glomerulonephritis].
    Sasinka M; Plenta I; Kaiserová E; Izakovic V; Pavlovic M; CYTEMBENA/*THER USE ; Slugen I; Lehký M; Stubna J
    Cesk Pediatr; 1976 Mar; 31(3):127-30. PubMed ID: 773556
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
    Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-immunological evaluation of the levamisole treatment of chronic glomerulonephritis patients].
    Pyrig LA; Kolesnik NA
    Vrach Delo; 1983 Mar; (3):95-8. PubMed ID: 6858119
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cell-mediated immunity and effects of cyclophosphamide on primary nephrotic syndrome (author's transl)].
    Okura T; Matsuo S; Kumon S; Hibi I; Tamaki S; Watanabe Y; Kinoshita Y
    Nihon Jinzo Gakkai Shi; 1981 Nov; 23(11):1395-403. PubMed ID: 7334719
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological studies of the mechanism of the therapeutic action of azathioprine and of indomethacin in chronic active glomerulonephritis and the nephrotic syndrome].
    Campanacci L; Castellani A; Gambari PF; Huber W; Fagiolo U; Vesco F; Contini MG; Rebecca L
    Minerva Nefrol; 1970; 17(4):127-50. PubMed ID: 4102147
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pentoxifylline (Trental) in the treatment of chronic glomerulonephritis].
    Shoĭkhet IN; Treĭvish VS; Novikova NN
    Ter Arkh; 1986; 58(8):71-3. PubMed ID: 3764765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide in the treatment of glomerulonephritis.
    Ibels LS; Palmer AA; Mahony JF; Stewart JH
    Prog Biochem Pharmacol; 1974; 9():65-81. PubMed ID: 4438383
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antistreptococcal antibodies in the blood serum of glomerulonephritis patients].
    Nanchikeeva ML; Mukhin NA; Poliantseva LR; Kozlovskaia LV; Briko NI
    Ter Arkh; 1992; 64(6):57-60. PubMed ID: 1440340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long term therapy of nephrotic syndrome and chronic glomerulonephritis in childhood].
    Bläker F
    Monatsschr Kinderheilkd (1902); 1970 Aug; 118(8):498-504. PubMed ID: 4995922
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of combined immunosuppressive-cytostatic treatment on antibody-dependent cellular cytotoxicity of patients with chronic glomerulonephritis.
    Láng I; Fekete B; Kenéz B; Nagy ZK; Gergely P
    Acta Med Acad Sci Hung; 1977; 34(4):247-50. PubMed ID: 618056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
    Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
    Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.